EMBL Ventures
Investor profile
EMBL Ventures has backed 3 European tech companies across 4 funding rounds between 2015 and 2021, joining rounds totalling €63M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
4
distinct rounds
Companies
3
backed
Active span
2015–2021
7 yrs
Total round €
€63M
sum of rounds joined
Deals by year
distinct rounds / yearEMBL Ventures — deals by year — interactive chart.
Data table
| EMBL Ventures — deals by year | |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2021 | 1 |
Top sectors
by dealsEMBL Ventures — top sectors — interactive chart.
Data table
| EMBL Ventures — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsEMBL Ventures — stages — interactive chart.
Data table
| EMBL Ventures — stages | |
|---|---|
| Series A | 2 |
| Series B | 2 |
Countries
by dealsEMBL Ventures — countries — interactive chart.
Data table
| EMBL Ventures — countries | |
|---|---|
| Germany | 4 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Allecra Therapeutics | Germany | 2 | €37M |
| Topas Therapeutics | Germany | 1 | €18M |
| Luxendo | Germany | 1 | €8.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Allecra Therapeutics | Series B | €22M | 2016-06 |
| Topas Therapeutics | Series B | €18M | 2021-07 |
| Allecra Therapeutics | Series A | €15M | 2015-04 |
| Luxendo | Series A | €8.0M | 2017-01 |